VectorY Therapeutics
Manufacturing · Netherlands · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Matrix Innovation Center 408, Amsterdam,...Phone Number
+31 202268020Website
www.vectorytx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About VectorY Therapeutics
Based out of Amsterdam, The Netherlands, VectorY Therapeutics is a biotechnology company with a focus on muscular and neurodegenerative disorders. The company was founded in 2020.Explore more
VectorY Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VectorY Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
VectorY Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at VectorY Therapeutics
Earning: See what the market has to say on VectorY Therapeutics recently announced quarterly report
Check if VectorY Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when VectorY Therapeutics launches new products
Check out if VectorY Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once VectorY Therapeutics has new funding data
Click to see if VectorY Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
VectorY Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VectorY Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VectorY Therapeutics.
VectorY Therapeutics financials insights
Gather financial insights about VectorY Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$37.6M
2023
Series A
$138M
VectorY Therapeutics Tech Stack
A closer look at the technologies used by VectorY Therapeutics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Executive Move
Executive Moves, Board of Directors
VectorY Therapeutics News & Media
VectorY Therapeutics Appoints Jessica Atkinson as Chief Business Officer
AMSTERDAM & BOSTON--(BUSINESS WIRE)-- #AAVVectors--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced the appointment of Jessica Atkinson as Chief Business Officer (CBO). In this newly created role, Atkinson will partner with the Chief Executive Officer and management team to develop long-term business and commercial strategies that support company growth, and will also drive strategicVectorY Therapeutics Announces Multiple Presentations at Upcoming American Society of Gene and Cell Therapy Annual Meeting 2025
AMSTERDAM & BOSTON--(BUSINESS WIRE)-- #AAAbaseddelivery--VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced that it will have four featured data presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 13-17, 2025 in New Orleans, Louisiana. "Our presentations at ASGCT showcase the outstanding work of VectorY scientists andVectorY Therapeutics Appoints Olga Uspenskaya-Cadoz as Chief Medical Officer
AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics has appointed Olga Uspenskaya-Cadoz as Chief Medical Officer. The appointment strengthens the clinical leadership at VectorY.VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO
AMSTERDAM & BOSTON--(BUSINESS WIRE)-- #GeneTherapy--VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, announces the appointment of Jim Scibetta as Chief Executive Officer. Former CEO and founder Sander van Deventer, will become President of R&D, and will continue to drive the development of VectorY’s pipeline including its lead program, VTx-002, a novel vectorized antibody targeting TDP-43 for the treatmen
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VectorY Therapeutics
Sign Up For FreeTo access detailed company insights
Based out of Amsterdam, The Netherlands, VectorY Therapeutics is a biotechnology company with a focus on muscular and neurodegenerative disorders. The company was founded in 2020.... Read More
